Recall Radar

Disclaimer: Recall Radar is an informational summary of public FDA enforcement reports. It is not medical advice. Always confirm details with the FDA, the company, a pharmacist, or a doctor before making health decisions.

← All recalls · Drug recalls

Class IIDrug

niCARdipine Hydrochloride Injection recall

Summary

American Regent, Inc. is recalling niCARdipine Hydrochloride Injection (drug). According to the FDA report, the reason is: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde. The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.

Details from the FDA report

Product
niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.
Reason
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Lot / code info
Lot #: 25295N0C0, Exp. Date: 04/30/2027.
Quantity
43,460 vials
Distribution
Nationwide within the U.S
Recalling company
American Regent, Inc., Shirley, NY United States
Recall started
July 24, 2026
FDA report date
August 26, 2026
Classification
Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
Voluntary / mandated
Voluntary: Firm initiated
Status
Ongoing
Recall number
D-0802-2026

What to do

View the FDA source record (openFDA) · FDA recalls page

Helpful guides

All guides

Get recall alerts by email

One short digest when new FDA food, supplement or drug recalls are posted, with the most serious (Class I) first. Free; unsubscribe anytime.

Powered by Buttondown. You may need to confirm your address by email.